Principle Criteria
Free Enterprise
Property Rights
Personal Responsibility
Limited Government
Individual Liberty
Digest
SB 2674 mandates that health benefit plans cover biomarker testing when used for diagnosing, treating, managing, or monitoring diseases or conditions, including post-organ transplant conditions. Coverage is required if the test is supported by FDA approval, Medicare coverage determinations, clinical practice guidelines, or medical consensus statements. The law applies to health plans issued or renewed on or after January 1, 2026.
Author
Juan Hinojosa
Contact the Author
Sen. Juan Hinojosa
Capitol Phone:
(512) 463-0120
Capitol Office:
CAP 3E.6
E-Mail:
